Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2092]
News [6483]
Articles [133]
Editorials [5]
Conferences [171]
elearning [10]
The role of AKT in chronic lymphocytic leukaemia transformation to Richter's...
Dr Christian Pallasch, University Hospital of Cologne, Cologne, Germany
The role of AKT in chronic lymphocytic leukaemia transformation to Richter's syndrome ( Dr Christian Pallasch, University Hospital of Cologne, Cologne, Germany )
12 Jun 2016
Targeted genome editing in haematopoeitic stem cells
Prof Luigi Naldini - Universita Vita-Salute San Raffaele, Milan, Italy
Targeted genome editing in haematopoeitic stem cells ( Prof Luigi Naldini - Universita Vita-Salute San Raffaele, Milan, Italy )
11 Jun 2016
A microRNA driver of B-cell leukaemia
Prof Luigi Naldini - Universita Vita-Salute San Raffaele, Milan, Italy
A microRNA driver of B-cell leukaemia ( Prof Luigi Naldini - Universita Vita-Salute San Raffaele, Milan, Italy )
11 Jun 2016
Risk adapted therapy for acute myeloid leukaemia
Prof Jorge Sierra - Hospital de Sant Pau, Barcelona, Spain
Risk adapted therapy for acute myeloid leukaemia ( Prof Jorge Sierra - Hospital de Sant Pau, Barcelona, Spain )
11 Jun 2016
Clinical characteristics and prognostic factors of plasmablastic lymphoma...
Dr Emmanuelle Tchernonog - CHRU Montpellier, Montpellier, France
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients ( Dr Emmanuelle Tchernonog - CHRU Montpellier, Montpellier, France )
11 Jun 2016
Killer antibodies against AML
Dr Mette Hazenberg - AMC, Amsterdam, The Netherlands
Killer antibodies against AML ( Dr Mette Hazenberg - AMC, Amsterdam, The Netherlands )
11 Jun 2016
Activated JAK-STAT signaling co-operates with HOXA9 to drive leukaemia
Dr Charles De Bock - KU Leuven, Leuven, Belgium
Activated JAK-STAT signaling co-operates with HOXA9 to drive leukaemia ( Dr Charles De Bock - KU Leuven, Leuven, Belgium )
10 Jun 2016
Pre-leukaemic clones that survive chemo linked to higher risk of AML recurrence
Dr Klaus Metzeler - Ludwig-Maximilians-Universität, Munich, Germany
Pre-leukaemic clones that survive chemo linked to higher risk of AML recurrence ( Dr Klaus Metzeler - Ludwig-Maximilians-Universität, Munich, Germany )
10 Jun 2016
Stopping tyrosine kinase inhibitors in CML
Dr Johan Richter - Lund University, Sweden
Stopping tyrosine kinase inhibitors in CML ( Dr Johan Richter - Lund University, Sweden )
10 Jun 2016
Sequencing analysis with circulating DNA
Dr Oliver Zill - Guardant Health Inc, Brentwood City, USA
Sequencing analysis with circulating DNA ( Dr Oliver Zill - Guardant Health Inc, Brentwood City, USA )
6 Jun 2016
Preliminary results from KEYNOTE-055: pembrolizumab in HNSCC
Dr Joshua Bauml - University of Pennsylvania, Philadelphia, USA
Preliminary results from KEYNOTE-055: pembrolizumab in HNSCC ( Dr Joshua Bauml - University of Pennsylvania, Philadelphia, USA )
6 Jun 2016
Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma
Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA
Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma ( Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA )
6 Jun 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation